Am J Physiol Cell Physiol Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 296: C1178-C1184, 2009. First published March 11, 2009; doi:10.1152/ajpcell.00291.2008
0363-6143/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Corrigendum
Right arrow All Versions of this Article:
296/5/C1178    most recent
00291.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Villarreal, F.
Right arrow Articles by Brunton, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Villarreal, F.
Right arrow Articles by Brunton, L. L.

EXTRACELLULAR MATRIX, CELL INTERACTIONS

Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for Epac and PI3K

Francisco Villarreal,*,1 Sara A. Epperson,*,3 Israel Ramirez-Sanchez,1 Katrina G. Yamazaki,1 and Laurence L. Brunton1,2

Departments of 1Medicine and 2Pharmacology and 3Biomedical Sciences PhD Program, Univeristy of California, San Diego School of Medicine, La Jolla, California

Submitted 2 June 2008 ; accepted in final form 3 March 2009

Rat cardiac fibroblasts (CF) express multiple adenosine (ADO) receptors. Pharmacological evidence suggests that activation of A2 receptors may inhibit collagen synthesis via adenylyl cyclase-induced elevation of cellular cAMP. We have characterized the signaling pathways involved in ADO-mediated inhibition of collagen synthesis in primary cultures of adult rat CF. ANG II stimulates collagen production in these cells. Coincubation with agents that elevate cellular cAMP [the ADO agonist, 5'-N-ethylcarboxamidoadensoine (NECA), and forskolin] inhibited the stimulatory effects of ANG II. However, direct stimulators and inhibitors of protein kinase A (PKA) did not alter ANG II-induced collagen synthesis, indicating that PKA does not mediate the inhibitory effects of NECA. Inhibitors of AMP-kinase (AMPK) and extracellular signal-regulated kinase 1/2 (ERK1/2) do not alter NECA-inhibited collagen synthesis. However, activation of exchange factor directly activated by cAMP (Epac) mimicked the effects of NECA on ANG II-stimulated collagen synthesis. Inhibition of phosphoinositol-3 kinase (PI3K) reduced the inhibitory effects of NECA on ANG II-induced collagen synthesis, suggesting that NECA acts via PI3K. Furthermore, inhibition of PI3K also relieved the inhibitory effect of Epac activation on ANG II-stimulated collagen synthesis. Thus it appears that ADO activates the A2R-Gs-adenylyl cyclase pathway and that the resultant cAMP reduces collagen synthesis via a PKA-independent, Epac-dependent pathway that feeds through PI3K.

A2 receptors; Epac; phosphoinositol-3 kinase; cardiac collagen deposition



Address for reprint requests and other correspondence: F. Villarreal, 9500 Gilman Dr., 0613J, BSB 4028, La Jolla, CA 92093 (e-mail: fvillarr{at}ucsd.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.